Trials / Not Yet Recruiting
Not Yet RecruitingNCT06819202
Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function
Effect of Hyperbaric Oxygen Therapy on Patients With Sudden Sensorineural Hearing Loss and Coagulation Function
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,309 (estimated)
- Sponsor
- Sun Yuting · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis. The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL. The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hyperbaric oxygen treatment | HBO therapy is the process of inhaling 100% pure oxygen in an environment above one atmosphere (pressure range: 2.0-3.0 absolute atmospheres) to treat a disease. |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-06-01
- Completion
- 2025-12-01
- First posted
- 2025-02-11
- Last updated
- 2025-05-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06819202. Inclusion in this directory is not an endorsement.